Dr. Quay talks to ABC7 about the Coronavirus HOPE Clinical Trial

Dr. Steven Quay, CEO of Atossa Therapeutics, proposes a combination of two FDA-approved drugs, heparin and N-acetylcysteine (NAC), to prevent COVID-19 patients from needing ventilators by disrupting the virus’s ability to enter the lungs.

Dubbed H-NAC, this drug combination aims to create a barrier against the virus, akin to peanut butter on car keys hindering access. Quay advocates for a clinical trial, hoping to start within 30 days, with the goal of enabling most COVID-19 patients to manage symptoms at home, reducing hospitalizations and associated risks.

The trial, named the COVID-19 Hope Trial, seeks to demonstrate the effectiveness of H-NAC administered through nebulizers, potentially revolutionizing treatment and alleviating strain on healthcare systems if successful.

Watch and read more here on ABC 7 News.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Dr. Steven Quay is joined by Senator Rand Paul and Richard H. Ebright, Board of Governors professor of chemistry and chemical biology at Rutgers University. They discuss the lab leak theory of COVID-19 in detail.

Dr. Steven Quay testified to the Senate that the coronavirus came from a lab in Wuhan, China. His reasons include the timing of the virus's emergence, research activities at the Wuhan Institute of Virology, and the genomic sequence of the virus. Quay also criticized China's concealment of information and expressed concerns about risky research at the lab.

In a recent conversation on The Vince Coglianese Show, Dr. Steven Quay shares his thoughts on various aspects of the COVID-19 pandemic, shedding light on critical issues ranging from the origins of the virus to the trust deficit in the medical community.